Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 14, 2018; 24(38): 4403-4411
Published online Oct 14, 2018. doi: 10.3748/wjg.v24.i38.4403
Published online Oct 14, 2018. doi: 10.3748/wjg.v24.i38.4403
HCV n = 490 (%) | Non-HCV n = 704 (%) | P value | |
Age (yr) | 56 ± 7.8 | 55 ± 10 | ns |
Gender (male) | 393 (80) | 532 (75.5) | ns |
BMI | 25 ± 4 | 25 ± 4 | ns |
Blood group | ns | ||
0 | 206 (42) | 311 (44.2) | |
A | 199 (40.6) | 282 (40) | |
AB | 19 (3.8) | 30 (4.3) | |
B | 66 (13.4) | 81 (11.5) | |
HCC (yes) | 303 (61.8) | 295 (42) | 0.001 |
Child-Pugh classes | 0.04 | ||
A | 137 (28) | 163 (23) | |
B | 185 (38) | 252 (36) | |
C | 168 (34) | 289 (41) | |
MELD at WL registration | 15 ± 6 | 16.7 ± 6.8 | 0.01 |
- Citation: Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411
- URL: https://www.wjgnet.com/1007-9327/full/v24/i38/4403.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i38.4403